Adam Dahlberg bought 178,388 shares in medical technology company Senzime on 28 September, where he is a board member. The shares were bought at a price of SEK 2.71 per share, a transaction worth SEK 484,100. The transaction was carried out on Nasdaq Stockholm. This is shown in the Swedish Financial Supervisory Authority’s insider register.
On 26 June, Dahlberg owned 7.69 million shares, corresponding to 4.89 percent of the capital and votes in Senzime, according to ownership service Holdings.
